Company intelligence / Profile preview

Allgens Medical

Beijing, Beijing, Chinaen.allgensmed.cn ↗

Ownership: Private
Employees: ~151
Development stage: Commercial

Overview

Allgens Medical has developed and commercialized a series of mineralized collagen bionic bone materials with composition and structure highly similar to natural human bone. These products are widely used in orthopedics, stomatology, neurosurgery, and plastic surgery for the regenerative repair of various types of bone defects. The company’s technologies have been validated in more than one million clinical cases.

Therapeutic areas: OtherNeurology
Modalities: BiologicSynthetic bone graft materialBiomimetic mineralized collagen artificial bone
Industry: Implantable Medical Devices

Drug pipeline

3 assets

BONGOLD

Commercial

Indications: Bone defect repair

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Allgens Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allgens Medical.

Explore the full profile